Nepedia
Back to Discover
Advanced Reader
🧬

Hematopoietic stem cell

life science Maturity 11-13 Next article →

Hematopoietic stem cells, or HSCs, are the essential foundation of the entire blood system. These unique cells are responsible for a process called haematopoiesis, which is the production of all mature blood cells. HSCs are characterized as multipotent, meaning they have the capacity to differentiate into many different specialized cell types. They also possess the ability for extensive self-renewal, allowing them to create more stem cells to maintain their own population. This balance is vital because the average human produces more than 500 billion blood cells every single day. Without the constant work of HSCs, the body could not regulate the necessary levels of blood cells in circulation.

Hematopoiesis (human) diagram en
Hematopoiesis (human) diagram en

The mechanism of blood production follows specific biological pathways known as lineages. HSCs divide into two primary lines: the myeloid lineage and the lymphoid lineage. The myeloid line produces various cells, including erythrocytes (red blood cells), megakaryocytes (which become platelets), and several white blood cells like neutrophils, basophils, eosinophils, macrophages, and monocytes. The lymphoid line is responsible for producing T cells, B cells, natural killer cells, and innate lymphoid cells. Both lineages contribute to the formation of dendritic cells. This complex system ensures that every specific type of cell required for oxygen transport, clotting, and immunity is constantly replenished.

Hematopoiesis (human) diagram en
Hematopoiesis (human) diagram en

HSCs exist in several distinct subtypes and states during their life cycle. Some are classified as colony-forming units (CFUs), which are categorized by the specific cells they produce. Examples include CFU-GEMM, which produces several myeloid types, and CFU-L, which leads to the lymphoid line. There are also more specific units like CFU-E for erythrocytes or CFU-Meg for megakaryocytes. Additionally, HSCs often exist in a state of quiescence, which is a form of reversible growth arrest. This dormant state is a survival mechanism. It allows the cells to endure the hypoxic, or low-oxygen, environment of the bone marrow. When the body experiences cell death or damage, these cells exit quiescence to begin active division.

Hematopoiesis (human) diagram en
Hematopoiesis (human) diagram en

The history of our understanding of these cells dates back to their discovery in 1961. Since then, scientists have mapped their complex locations throughout development. In vertebrate embryos, the first definitive HSCs arise from the ventral endothelial wall of the embryonic aorta. This occurs in the aorta-gonad-mesonephros (AGM) region through endothelial-to-hematopoietic transition. As development continues, HSCs can be found in the yolk sac, placenta, umbilical arteries, and the fetal liver. In adults, the process shifts primarily to the red bone marrow located in the core of most bones. Recent global discoveries have even identified HSC niches within invertebrate skeletons, challenging the idea that skeletal haematopoiesis is unique to vertebrates.

Hematopoiesis (human) diagram en
Hematopoiesis (human) diagram en

The clinical significance of HSCs is most evident in hematopoietic stem cell transplantation (HSCT). This medical procedure is used to treat life-threatening conditions like leukemia, multiple myeloma, and various immune system disorders. Transplants can be autologous, using the patient's own cells, or allogeneic, using cells from a donor. They can also be syngeneic, using cells from an identical twin. Because HSCs are rare—making up only about 1:10,000 of cells in myeloid tissue—doctors must use specialized methods to find them. They use flow cytometry to identify specific surface markers, such as CD34, to isolate these cells from the surrounding blood.

Hematopoiesis (human) diagram en
Hematopoiesis (human) diagram en

As organisms age, the health of the hematopoietic system undergoes significant changes. One major factor is the accumulation of DNA damage within long-term HSCs. The body relies on a repair pathway called non-homologous end joining (NHEJ) to fix double-strand breaks in DNA. This pathway requires specific proteins, including DNA ligase 4 and NHEJ factor 1. If these proteins are deficient, it can lead to a progressive loss of stem cells and premature aging. Research suggests that clonal diversity, or the variety of different stem cell lines, can decrease drastically around age 70. This loss of diversity is a key part of how the blood system changes over a lifetime.

Hematopoiesis (human) diagram en
Hematopoiesis (human) diagram en

Understanding HSCs connects many different fields of science, from embryology to oncology. The study of the "stem cell niche," the specific environment in the bone marrow, helps researchers understand how molecular signals trigger self-renewal. Scientists are currently investigating how to expand these cell populations in vitro, which means in a controlled laboratory setting. If successful, this could lead to new ways to regenerate tissues or provide more abundant supplies for transplants. By studying how HSCs move through the body and respond to physiological stress, researchers hope to unlock new therapies for both blood diseases and general aging.

755 words

Where will your curiosity go next?

Keep exploring at your chosen reading level.

🖼️ Images & Media (1)
File:Hematopoiesis (human) diagram en.svg
Hematopoiesis (human) diagram en.svg
More to explore

🔬 Go deeper

More advanced topics to explore

🪜 Step back

Simpler topics to build understanding

What is Nepedia?

A free, ad-free encyclopedia for children. Every article is written at five reading levels, so the same page works for a five-year-old and a fifteen-year-old — use the level switcher above to see this one change. No account needed to read.